TransMedics Group, Inc. cotiza a 78.17 USD y tiene una capitalización bursátil de $2.7B. En los últimos 12 meses ha facturado $668M con un margen de flujo de caja libre del 22.1%. Cotiza a 34.3 veces su flujo de caja libre (P/FCF) y a un PER de 17.9. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utili…
| Periodo | 2026-10 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.44 | $0.30 | $0.53 |
| Estimado | $0.29 | $0.48 | $0.61 | $0.37 |
| Sorpresa | — | -8.3% | -50.8% | +43.2% |
| Métrica | TMDX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 59.9% | 57.0% | +2.9% |
| Operating Margin | 17.9% | -38.6% | +56.5% |
| Net Margin | 31.4% | -33.6% | +65.0% |
| FCF Margin | 22.1% | -13.9% | +35.9% |
| ROE | 40.2% | -40.4% | +80.6% |
| ROA | 17.8% | -32.0% | +49.8% |
| Current Ratio | 7.14 | 2.84 | +4.30 |
| Debt / Equity | — | 0.28 | — |